Circuit Clinical extends biobanking, genetics, and big data capabilities

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Goja1)
(Image: Getty/Goja1)

Related tags: Circuit Clinical, Biobanking, Genetics, Big data

Circuit Clinical partners with the University at Buffalo’s genomics and biorepository program to add personalized medicine capabilities to its service offering lineup.

The integrated research organization (IRO) Circuit Clinical has worked closely with the University at Buffalo (UB) since 2015 when the school first sponsored the company for the STARTUP-NY innovation program​. This led to a 5-year $1.1m development grant from UB's Buffalo Institute for Genomics and Data Analytics the following year.

UB’s Center for Advanced Technology recently awarded Circuit Clinical two grants and is currently collaborating with the organization on a Small Business Innovation Research (SBIR​) Phase II grant submission.

Dr. Irfan Khan, founder and CEO of Circuit Clinical said the most recent partnership, announced this month, is focused on leveraging UB's biospecimens storage, processing, and genetic sequencing capabilities with Circuit Clinical's engagement platform, TrialScout, and its corresponding clinical research network of approximately 1m patients.

“We envision that this public-private partnership will execute highly targeted biospecimens and patient-permissioned EMR [electronic medical record] data collection to create truly deep datasets that can be mined for big data insights over time,” ​he told us.

Khan added, “We believe that partnering to extend our capabilities in biobanking, genetics, and big data - all while running an effective clinical trial network and building a transformative patient engagement platform - have put Circuit Clinical in a unique position to disrupt personalized medicine.”

Related news

Show more

Related products

show more

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars